PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection

Yong Zhang; Dailing Mao; William T. Roswit; Xiaohua Jin; Anand C. Patel; Dhara A. Patel; Eugene Agapov; Zhepeng Wang; Rose M. Tidwell; Jeffrey J. Atkinson; Guangming Huang; Ronald McCarthy; Jinsheng Yu; Nadezhda E. Yun; Slobodan Paessler; T. Glen Lawson; Natalie S. Omattage; Tom J. Brett; Michael J. Holtzman

doi:10.1038/ni.3279

PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection

Yong Zhang, Dailing Mao, William T. Roswit, Xiaohua Jin, Anand C. Patel, Dhara A. Patel, Eugene Agapov, Zhepeng Wang, Rose M. Tidwell, Jeffrey J. Atkinson, Guangming Huang, Ronald McCarthy, Jinsheng Yu, Nadezhda E. Yun, Slobodan Paessler, T. Glen Lawson, Natalie S. Omattage, Tom J. Brett, Michael J. Holtzman

Pathology

Research output: Contribution to journal › Article › peer-review

163 Scopus citations

Abstract

Enhancing the response to interferon could offer an immunological advantage to the host. In support of this concept, we used a modified form of the transcription factor STAT1 to achieve hyper-responsiveness to interferon without toxicity and markedly improve antiviral function in transgenic mice and transduced human cells. We found that the improvement depended on expression of a PARP9-DTX3L complex with distinct domains for interaction with STAT1 and for activity as an E3 ubiquitin ligase that acted on host histone H2BJ to promote interferon-stimulated gene expression and on viral 3C proteases to degrade these proteases via the immunoproteasome. Thus, PARP9-DTX3L acted on host and pathogen to achieve a double layer of immunity within a safe reserve in the interferon signaling pathway.

Original language	English (US)
Pages (from-to)	1215-1227
Number of pages	13
Journal	Nature Immunology
Volume	16
Issue number	12
DOIs	https://doi.org/10.1038/ni.3279
State	Published - Dec 1 2015

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1038/ni.3279

Cite this

Zhang, Y., Mao, D., Roswit, W. T., Jin, X., Patel, A. C., Patel, D. A., Agapov, E., Wang, Z., Tidwell, R. M., Atkinson, J. J., Huang, G., McCarthy, R., Yu, J., Yun, N. E., Paessler, S., Lawson, T. G., Omattage, N. S., Brett, T. J., & Holtzman, M. J. (2015). PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection. Nature Immunology, 16(12), 1215-1227. https://doi.org/10.1038/ni.3279

Zhang, Y, Mao, D, Roswit, WT, Jin, X, Patel, AC, Patel, DA, Agapov, E, Wang, Z, Tidwell, RM, Atkinson, JJ, Huang, G, McCarthy, R, Yu, J, Yun, NE, Paessler, S, Lawson, TG, Omattage, NS, Brett, TJ & Holtzman, MJ 2015, 'PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection', Nature Immunology, vol. 16, no. 12, pp. 1215-1227. https://doi.org/10.1038/ni.3279

@article{b7c243185b014363840ae773fc2908ef,

title = "PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection",

abstract = "Enhancing the response to interferon could offer an immunological advantage to the host. In support of this concept, we used a modified form of the transcription factor STAT1 to achieve hyper-responsiveness to interferon without toxicity and markedly improve antiviral function in transgenic mice and transduced human cells. We found that the improvement depended on expression of a PARP9-DTX3L complex with distinct domains for interaction with STAT1 and for activity as an E3 ubiquitin ligase that acted on host histone H2BJ to promote interferon-stimulated gene expression and on viral 3C proteases to degrade these proteases via the immunoproteasome. Thus, PARP9-DTX3L acted on host and pathogen to achieve a double layer of immunity within a safe reserve in the interferon signaling pathway.",

author = "Yong Zhang and Dailing Mao and Roswit, {William T.} and Xiaohua Jin and Patel, {Anand C.} and Patel, {Dhara A.} and Eugene Agapov and Zhepeng Wang and Tidwell, {Rose M.} and Atkinson, {Jeffrey J.} and Guangming Huang and Ronald McCarthy and Jinsheng Yu and Yun, {Nadezhda E.} and Slobodan Paessler and Lawson, {T. Glen} and Omattage, {Natalie S.} and Brett, {Tom J.} and Holtzman, {Michael J.}",

note = "Publisher Copyright: {\textcopyright} 2015 Nature America, Inc.",

year = "2015",

month = dec,

day = "1",

doi = "10.1038/ni.3279",

language = "English (US)",

volume = "16",

pages = "1215--1227",

journal = "Nature Immunology",

issn = "1529-2908",

publisher = "Nature Research",

number = "12",

}

TY - JOUR

T1 - PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection

AU - Zhang, Yong

AU - Mao, Dailing

AU - Roswit, William T.

AU - Jin, Xiaohua

AU - Patel, Anand C.

AU - Patel, Dhara A.

AU - Agapov, Eugene

AU - Wang, Zhepeng

AU - Tidwell, Rose M.

AU - Atkinson, Jeffrey J.

AU - Huang, Guangming

AU - McCarthy, Ronald

AU - Yu, Jinsheng

AU - Yun, Nadezhda E.

AU - Paessler, Slobodan

AU - Lawson, T. Glen

AU - Omattage, Natalie S.

AU - Brett, Tom J.

AU - Holtzman, Michael J.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Enhancing the response to interferon could offer an immunological advantage to the host. In support of this concept, we used a modified form of the transcription factor STAT1 to achieve hyper-responsiveness to interferon without toxicity and markedly improve antiviral function in transgenic mice and transduced human cells. We found that the improvement depended on expression of a PARP9-DTX3L complex with distinct domains for interaction with STAT1 and for activity as an E3 ubiquitin ligase that acted on host histone H2BJ to promote interferon-stimulated gene expression and on viral 3C proteases to degrade these proteases via the immunoproteasome. Thus, PARP9-DTX3L acted on host and pathogen to achieve a double layer of immunity within a safe reserve in the interferon signaling pathway.

AB - Enhancing the response to interferon could offer an immunological advantage to the host. In support of this concept, we used a modified form of the transcription factor STAT1 to achieve hyper-responsiveness to interferon without toxicity and markedly improve antiviral function in transgenic mice and transduced human cells. We found that the improvement depended on expression of a PARP9-DTX3L complex with distinct domains for interaction with STAT1 and for activity as an E3 ubiquitin ligase that acted on host histone H2BJ to promote interferon-stimulated gene expression and on viral 3C proteases to degrade these proteases via the immunoproteasome. Thus, PARP9-DTX3L acted on host and pathogen to achieve a double layer of immunity within a safe reserve in the interferon signaling pathway.

UR - http://www.scopus.com/inward/record.url?scp=84947866665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947866665&partnerID=8YFLogxK

U2 - 10.1038/ni.3279

DO - 10.1038/ni.3279

M3 - Article

C2 - 26479788

AN - SCOPUS:84947866665

SN - 1529-2908

VL - 16

SP - 1215

EP - 1227

JO - Nature Immunology

JF - Nature Immunology

IS - 12

ER -

PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this